Last updated on February 2018

Platine Avastin and OLAparib in 1st Line

Brief description of study

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance.

Detailed Study Description

Patients with advanced FIGO stage IIIB - IV high grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer treated with standard first-line treatment, combining platinum-taxane chemotherapy and bevacizumab concurrent with chemotherapy and in maintenance.

Clinical Study Identifier: NCT02477644

Contact Investigators or Research Sites near you

Start Over

Wencke Ruhwedel, MD

Klinkum G tersloh
Gütersloh, Germany
  Connect »